Engineering the Lung Microenvironment
Timeslot: Thursday, April 28, 2022 - 10:30am to 12:00pm
Room: Laurel C-D, 4th
The COVID-19 pandemic has put lung health in the spotlight. Advances in biomaterial design and microfabrication offer the potential to create in vitro models of the pulmonary microenvironment. These models can be used to develop treatments for acute conditions such as COVID-19, to investigate mechanisms of chronic disease progression, for toxicology testing, and may even eliminate the need for animal experimentation in the future. This symposium will focus on the opportunities associated with using biomaterials to engineer the lung microenvironment and potential impacts on pulmonary medicine.
Abstracts will be available for download on April 27, 2022.
10:30:00 AM 146. INVITED SPEAKER: Daniel J Weiss, MD, PhD, University of Vermont
11:00:00 AM 147. Modeling Airway Dysfunction in Asthma Using Synthetic Mucus Biomaterials, Daniel Song*, Ethan Iverson, Logan Kaler, Margaret Scull, PhD, Gregg Duncan, PhD, University of Maryland, College Park, MD, USA
11:15:00 AM 148. 3D Lung Models for Studying Chronic Respiratory Diseases in vitro, Thomas Caracena, BS*, Rachel Blomberg, PhD, Chelsea Magin, PhD, University of Colorado, Denver
Anschutz, Aurora, CO, USA
11:30:00 AM 149. A 3D Multigeneration Lung Model to Study the Biofluid Mechanics of Intratracheal Drug Delivery, Hannah Combs*, Hossein Tavana, PhD, The University of Akron, Akron, OH, USA
11:45:00 AM 150. Pulmonary Arterial Fibroblast Activation in Response to Dynamic Microenvironmental Stiffness is Sex-Specific, Mikala Mueller, BS*, Chelsea Magin, PhD, University of Colorado, Denver and Anschutz Medical Campus, Aurora, CO, USA